Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AbbVie
AbbVie
Mario Negri Institute for Pharmacological Research
Shandong Cancer Hospital and Institute
Inspirna, Inc.
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
University of California, San Diego
Kyowa Kirin Co., Ltd.
Zhongnan Hospital
Loyola University
Banaras Hindu University
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Quest PharmaTech Inc.
Belgian Gynaecological Oncology Group
UConn Health
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
Hellenic Oncology Research Group
City of Hope Medical Center
The University of Texas Health Science Center at San Antonio
Children's Oncology Group
Sanofi
AstraZeneca
GlaxoSmithKline
Hellenic Oncology Research Group
AstraZeneca